These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 6861163)

  • 21. Phase I-II study of mitomycin C topical therapy for low-grade, low stage transitional cell carcinoma of the bladder: an interim report.
    DeFuria MD; Bracken RB; Johnson DE; Soloway MS; Merrin CE; Morgan LR; Miller HC; Crooke ST
    Cancer Treat Rep; 1980; 64(2-3):225-30. PubMed ID: 7407754
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A single-arm, multicenter, open-label phase 2 study of lapatinib as the second-line treatment of patients with locally advanced or metastatic transitional cell carcinoma.
    Wülfing C; Machiels JP; Richel DJ; Grimm MO; Treiber U; De Groot MR; Beuzeboc P; Parikh R; Pétavy F; El-Hariry IA
    Cancer; 2009 Jul; 115(13):2881-90. PubMed ID: 19399906
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Phase II study of 5-FU tablet in bladder tumor].
    Nagamoto A; Kubota Y; Shuin T; Kondo I; Moriyama M; Satomi Y; Fukushima S; Fukuoka H; Ishizuka E; Furuhata A
    Gan To Kagaku Ryoho; 1989 Apr; 16(4 Pt 1):845-50. PubMed ID: 2653223
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Phase II trial cisplatin, doxorubicin, and cyclophosphamide (CAP) in the treatment of urothelial transitional cell carcinoma.
    Campbell M; Baker LH; Opipari M; Al-Sarraf M
    Cancer Treat Rep; 1981; 65(9-10):897-9. PubMed ID: 7196800
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Primary cisplatin, methotrexate and vinblastine aiming at bladder preservation in invasive bladder cancer: multivariate analysis on prognostic factors.
    Angulo JC; Sanchez-Chapado M; Lopez JI; Flores N
    J Urol; 1996 Jun; 155(6):1897-902. PubMed ID: 8618282
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Treatment of advanced bladder cancer using cis-platinum.
    Harewood LM; Nunn I; Johnson W; Sullivan JR; Moon WJ; Leyden MJ
    Aust N Z J Surg; 1983 Aug; 53(4):333-7. PubMed ID: 6193775
    [TBL] [Abstract][Full Text] [Related]  

  • 27. European Organization for Research and Treatment of Cancer (EORTC) phase II study of low-dose weekly epirubicin in metastatic prostate cancer.
    Jones WG; Fosså SD; Bono AV; Klijn JG; De Pauw M; Sylvester R
    Cancer Treat Rep; 1987 Dec; 71(12):1317-8. PubMed ID: 3480046
    [No Abstract]   [Full Text] [Related]  

  • 28. Phase II chemotherapy trials of 5-FU, cyclophosphamide, ifosfamide, and vincristine in carcinoma of the bilharzial bladder.
    Gad-el-Mawla N; Ziegler JL; Hamza R; Elserafi M; Khaled H
    Cancer Treat Rep; 1984 Feb; 68(2):419-21. PubMed ID: 6697330
    [No Abstract]   [Full Text] [Related]  

  • 29. [Use of VM-26 as a single agent in the treatment of transitional cell carcinoma of the urinary tract].
    Aso Y; Ushiyama T; Suzuki K; Tajima A; Naide Y; Ohshima S; Matsuura O; Fukushima M; Ota K; Ono Y
    Nihon Gan Chiryo Gakkai Shi; 1988 May; 23(5):1046-51. PubMed ID: 3418215
    [No Abstract]   [Full Text] [Related]  

  • 30. Phase II study of VP 16-213 (etoposide) in metastatic transitional cell urothelial cancer.
    Ponder BA; Oliver RT
    Cancer Chemother Pharmacol; 1984; 12(1):64-5. PubMed ID: 6690078
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Use of azauridine in cancer of the urinary bladder].
    Erukhimov LS; Vermel' EM
    Vopr Onkol; 1969; 15(5):91. PubMed ID: 5360151
    [No Abstract]   [Full Text] [Related]  

  • 32. Phase II study of carboplatin in locally advanced and metastatic transitional cell carcinoma of the urinary bladder.
    Raabe NK; Fossa SD; Parø G
    Br J Urol; 1989 Dec; 64(6):604-7. PubMed ID: 2697452
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Metastatic carcinoma of the urinary bladder from primary tumors in the mammary gland of female patients.
    Perez-Mesa C; Pickren JW; Woodruff MN; Mohallatee A
    Surg Gynecol Obstet; 1965 Oct; 121(4):813-8. PubMed ID: 5838289
    [No Abstract]   [Full Text] [Related]  

  • 34. Teniposide in metastatic renal and bladder cancer: a Southwest Oncology Group Study.
    Oishi N; Berenberg J; Blumenstein BA; Johnson K; Rivkin SE; Bukowski RM; O'Bryan RM; Stephens RL; Quagliana J; Saiers JH
    Cancer Treat Rep; 1987 Dec; 71(12):1307-8. PubMed ID: 3690547
    [No Abstract]   [Full Text] [Related]  

  • 35. [Photodynamic therapy (PDT) of bladder cancer. Report of 21 cases].
    Xie JG
    Zhonghua Zhong Liu Za Zhi; 1985 Mar; 7(2):113-5. PubMed ID: 4006674
    [No Abstract]   [Full Text] [Related]  

  • 36. Vincristine treatment of advanced cancer: a cooperative study of 392 cases.
    Holland JF; Scharlau C; Gailani S; Krant MJ; Olson KB; Horton J; Shnider BI; Lynch JJ; Owens A; Carbone PP; Colsky J; Grob D; Miller SP; Hall TC
    Cancer Res; 1973 Jun; 33(6):1258-64. PubMed ID: 4352365
    [No Abstract]   [Full Text] [Related]  

  • 37. A phase II study of 4-epi-adriamycin in advanced urothelial transitional cell cancer. EORTC-GU Group protocol 30867.
    Fosså SD; Splinter T; Roozendaal KJ; Veenhof KH; Pavone-Macaluso M; Calciati A; de Pauw M; Sylvester R
    Eur J Cancer Clin Oncol; 1989 Feb; 25(2):389-90. PubMed ID: 2702991
    [No Abstract]   [Full Text] [Related]  

  • 38. Methotrexate in the treatment of metastatic and recurrent primary transitional cell carcinoma.
    Oliver RT; England HR; Risdon RA; Blandy JP
    J Urol; 1984 Mar; 131(3):483-5. PubMed ID: 6230463
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Phase II trial of amsacrine (AMSA) in urinary bladder cancer.
    Natale RB; Yagoda A; Blumenreich MS; Watson RC
    Cancer Treat Rep; 1983 Apr; 67(4):391-2. PubMed ID: 6687836
    [No Abstract]   [Full Text] [Related]  

  • 40. Hydroxyurea in bladder carcinoma.
    Beckloff GL; Lerner HJ; Cole DR; Kilger K
    Invest Urol; 1966 Mar; 3(5):530-4. PubMed ID: 5910752
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.